Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387661021> ?p ?o ?g. }
- W4387661021 endingPage "S304" @default.
- W4387661021 startingPage "S295" @default.
- W4387661021 abstract "The Antibacterial Resistance Leadership Group (ARLG) has prioritized infections caused by gram-positive bacteria as one of its core areas of emphasis. The ARLG Gram-positive Committee has focused on studies responding to 3 main identified research priorities: (1) investigation of strategies or therapies for infections predominantly caused by gram-positive bacteria, (2) evaluation of the efficacy of novel agents for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci, and (3) optimization of dosing and duration of antimicrobial agents for gram-positive infections. Herein, we summarize ARLG accomplishments in gram-positive bacterial infection research, including studies aiming to (1) inform optimal vancomycin dosing, (2) determine the role of dalbavancin in MRSA bloodstream infection, (3) characterize enterococcal bloodstream infections, (4) demonstrate the benefits of short-course therapy for pediatric community-acquired pneumonia, (5) develop quality of life measures for use in clinical trials, and (6) advance understanding of the microbiome. Future studies will incorporate innovative methodologies with a focus on interventional clinical trials that have the potential to change clinical practice for difficult-to-treat infections, such as MRSA bloodstream infections." @default.
- W4387661021 created "2023-10-17" @default.
- W4387661021 creator A5001916892 @default.
- W4387661021 creator A5003567187 @default.
- W4387661021 creator A5016777889 @default.
- W4387661021 creator A5018437292 @default.
- W4387661021 creator A5020973269 @default.
- W4387661021 creator A5021195672 @default.
- W4387661021 creator A5022097782 @default.
- W4387661021 creator A5027587575 @default.
- W4387661021 creator A5042546094 @default.
- W4387661021 creator A5045500368 @default.
- W4387661021 creator A5045967076 @default.
- W4387661021 creator A5050312610 @default.
- W4387661021 creator A5057825659 @default.
- W4387661021 creator A5061755175 @default.
- W4387661021 creator A5065536920 @default.
- W4387661021 creator A5065796311 @default.
- W4387661021 creator A5067425596 @default.
- W4387661021 creator A5068293016 @default.
- W4387661021 creator A5075229057 @default.
- W4387661021 creator A5076959994 @default.
- W4387661021 creator A5079680275 @default.
- W4387661021 creator A5081285167 @default.
- W4387661021 creator A5084249121 @default.
- W4387661021 creator A5087235524 @default.
- W4387661021 creator A5089096661 @default.
- W4387661021 creator A5089384391 @default.
- W4387661021 creator A5091592847 @default.
- W4387661021 date "2023-10-15" @default.
- W4387661021 modified "2023-10-17" @default.
- W4387661021 title "Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review" @default.
- W4387661021 cites W1864053219 @default.
- W4387661021 cites W1933023737 @default.
- W4387661021 cites W2010066166 @default.
- W4387661021 cites W2013314123 @default.
- W4387661021 cites W2092084708 @default.
- W4387661021 cites W2107770752 @default.
- W4387661021 cites W2108433768 @default.
- W4387661021 cites W2109144391 @default.
- W4387661021 cites W2116581803 @default.
- W4387661021 cites W2123010468 @default.
- W4387661021 cites W2123875999 @default.
- W4387661021 cites W2127768597 @default.
- W4387661021 cites W2134463868 @default.
- W4387661021 cites W2151348288 @default.
- W4387661021 cites W2161881689 @default.
- W4387661021 cites W2162420979 @default.
- W4387661021 cites W2167805911 @default.
- W4387661021 cites W2175925164 @default.
- W4387661021 cites W2280240373 @default.
- W4387661021 cites W2332831021 @default.
- W4387661021 cites W2521675026 @default.
- W4387661021 cites W2744274169 @default.
- W4387661021 cites W2811069563 @default.
- W4387661021 cites W2896665945 @default.
- W4387661021 cites W2898112342 @default.
- W4387661021 cites W2898649154 @default.
- W4387661021 cites W2901491938 @default.
- W4387661021 cites W2911100176 @default.
- W4387661021 cites W2912010632 @default.
- W4387661021 cites W2945921338 @default.
- W4387661021 cites W2948445695 @default.
- W4387661021 cites W2983326523 @default.
- W4387661021 cites W3012260518 @default.
- W4387661021 cites W3027529392 @default.
- W4387661021 cites W3047796918 @default.
- W4387661021 cites W3122104815 @default.
- W4387661021 cites W3122118092 @default.
- W4387661021 cites W3132239282 @default.
- W4387661021 cites W3139048443 @default.
- W4387661021 cites W3165050468 @default.
- W4387661021 cites W3188084363 @default.
- W4387661021 cites W3202070756 @default.
- W4387661021 cites W3209270662 @default.
- W4387661021 cites W4200197744 @default.
- W4387661021 cites W4200606460 @default.
- W4387661021 cites W4205658511 @default.
- W4387661021 cites W4206677002 @default.
- W4387661021 cites W4207016330 @default.
- W4387661021 cites W4214830080 @default.
- W4387661021 cites W4220699460 @default.
- W4387661021 cites W4223949280 @default.
- W4387661021 cites W4230357700 @default.
- W4387661021 cites W4231440822 @default.
- W4387661021 cites W4242318543 @default.
- W4387661021 cites W4280561604 @default.
- W4387661021 cites W4292024189 @default.
- W4387661021 cites W4294316341 @default.
- W4387661021 cites W4309411734 @default.
- W4387661021 cites W4312046058 @default.
- W4387661021 cites W4319455926 @default.
- W4387661021 doi "https://doi.org/10.1093/cid/ciad565" @default.
- W4387661021 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37843115" @default.
- W4387661021 hasPublicationYear "2023" @default.
- W4387661021 type Work @default.
- W4387661021 citedByCount "0" @default.
- W4387661021 crossrefType "journal-article" @default.